Secretory IgA, Inc. is an early stage drug discovery and development company.
The mission of this company is to develop orally available agents for the treatment of intestinal diseases mediated by bacterial toxins.
Secretory IgA, Inc. is an early stage drug discovery and development company.
The mission of this company is to develop orally available agents for the treatment of intestinal diseases mediated by bacterial toxins.
Laboratory
333 Parkland Plaza Drive
Ann Arbor, MI 48103 U.S.A.
E-mail address
MRSimon@SecretoryIgA.com
Web address
www.SecretoryIgA.com
Office phone
734-994-0966